Annual Henry Ford Cancer Thoracic Multidisciplinary Symposium (2026)

Friday, November 6, 2026, 7:00 AM - 3:30 PM, The Dearborn Inn, Dearborn, MI


AMA PRA Category 1 Credits™ (6.00 hours), ABIM MOC Part 2 (6.00 hours), AMA PRA Non-Physician Attendance (6.00 hours)

The 4th Annual Henry Ford Cancer Thoracic Multidisciplinary Symposium is an educational program offering the latest updates in the diagnosis and multidisciplinary management of lung cancer. Through expert lectures, panel discussions, and interactive case sessions, participants will: • Review advances in perioperative immunotherapy, targeted therapy, and surgical approaches for early stage NSCLC • Explore updates in systemic therapy for metastatic NSCLC, including antibody drug conjugates, bispecifics, and novel biomarkers (HER2, MET, ROS1, NRG) • Examine the evolving treatment landscape of small cell lung cancer • Gain insight from a patient advocate on the patient experience in lung cancer care and research This symposium is designed for oncologists, surgeons, radiation oncologists, pulmonologists, and other members of the thoracic cancer care team seeking practical, evidence based updates to improve patient outcomes.

1. Apply current evidence and guideline recommendations to multidisciplinary treatment planning for patients with early-stage and metastatic non-small cell lung cancer (NSCLC)
2. Evaluate molecular and biomarker findings to select appropriate targeted therapies and emerging treatment strategies for patients with NSCLC
3. Develop individualized, multidisciplinary treatment strategies for patients with thoracic malignancies, including small cell lung cancer and thymic malignancies, by incorporating evolving evidence, clinical trial data, and case-based considerations into clinical decision-making
4. Incorporate patient perspectives and multidisciplinary collaboration into treatment planning and shared decision-making to address patient preferences, treatment goals, and barriers across the lung cancer care continuum

If you are an employee of a pharmaceutical or device company, please see the exhibitor tab before registering.

Henry Ford Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

DESIGNATION STATEMENT:

Henry Ford Health designates this live course for a maximum of 6.00 AMA PRA Category 1 Credit(s) TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

 

FACULTY/PLANNING COMMITTEE DISCLOSURE STATEMENT: 

 In compliance with the ACCME standards for Commercial Support, all individuals in a position to control/influence the content of this activity are required to disclose all financial interests of their own with any ACCME defined commercial interests for the past 24 months and/or non-FDA approved use of a drug or a device that is included in the presentation. All financial relationships have been mitigated prior to the commencement of the activity.

 

ACCESSIBILITY STATEMENT: 

Henry Ford Health provides qualified interpreters and other aids for Deaf, DeafBlind, and Hard-of-Hearing persons at no cost. To request assistance, contact the event coordinator: [email protected]. Please allow a minimum of 3 days to process this request.

Cancellation Policy

Please send cancellation requests to [email protected].

Henry Ford Health Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

The Henry Ford Health Office of Continuing Medical Education adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Henry Ford Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

If your company is interested in supporting this event, please complete this form

If you are an employee of a pharmaceutical or device company and are interested in attending this event, your attendance must be organized by emailing [email protected]. Types of industry employees include PhDs, MSLs, pharmacologists, clinical research associates, sales reps, etc. Do not register on this webpage; your registration will be refunded.

Please visit our exhibitor website for more information.

If you have further inquiries, please email [email protected] and [email protected].